SECONDARY NEUTRON PRODUCTION IN PROTON THERAPY
This study focuses on the detailed characterization of secondary neutron production in proton therapy through Monte Carlo simulations using the GEANT4 toolkit. The primary objective is to analyze neutron yield, energy spectra, angular distribution, and the resulting dose deposited by these secondary particles in various clinical scenarios.
1. Newhauser, W. D., & Durante, M. (2011). Assessing the risk of second malignancies after modern radiotherapy. Nature Reviews Cancer, 11(6), 438-448.
2. Taddei, P. J., et al. (2008). Neutron production from beam-modifying devices in proton therapy. Physics in Medicine & Biology, 53(1), 236-257.
3. Hall, E. J. (2006). Radiobiology for the radiologist. Lippincott Williams & Wilkins.
4. Agostinelli, S., et al. (2003). GEANT4-a simulation toolkit. Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment, 506(3), 250-303.
5. Paganetti, H. (2012). Relative biological effectiveness (RBE) values for proton beam therapy: Variations as a function of biological endpoint, dose, and linear energy transfer. Physics in Medicine & Biology, 57(11), R75
Copyright (c) 2025 ACTA NUUz
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
.jpg)
1.png)
